By Eduardo D. Bruera, Russell K. Portenoy
This finished textual content surveys the original features of melanoma ache, together with its pathophysiology, scientific overview, analysis, pharmacological administration and nonpharmacological therapy. The the world over well-known members tackle the complete variety of disciplines focused on melanoma discomfort administration, together with pharmacology, conversation stories, and psychology. the amount is an important source for physicians, nurses, and scientific scholars treating sufferers struggling with melanoma ache.
Read or Download Cancer Pain: Assessment and Management PDF
Best anesthesiology books
ASA Refresher classes in Anesthesiology is the biggest promoting annual book in its box. every one new quantity comprises as much as twenty whole and edited peer-reviewed lectures on issues of present medical curiosity which are chosen from nearby and nationwide ASA Refresher path lectures.
Wer die Diplomprüfung der Europäischen Akademie für Anästhesiologie erfolgreich absolviert, hat entscheidende Vorteile bei der Bewerbung um eine Ausbildungsstelle. Sichern Sie sich Ihre qualifizierte Weiterbildung mit diesem Werk! Es umfaßt in zwei Bänden das gesamte Wissen für die zweiteilige Diplomprüfung.
View the cardiovascular method as merely Netter pictures can depict it. This spectacularly illustrated quantity, a part of the masterwork referred to as the Netter (CIBA) "Green Books," presents a hugely visible consultant to the guts, from easy technological know-how, anatomy, and body structure to pathology and damage. This vintage Netter reference has been up to date to reflect the numerous intriguing advances in cardiovascular drugs and imaging - supplying exceptional insights into anatomy, body structure, and scientific stipulations.
Additional resources for Cancer Pain: Assessment and Management
Bucher et al. (62) reported that 86% of patients had a problem with pain in the last 4 weeks of life. The prevalence of pain by primary tumor site Nine studies were identified that provided prevalence data on pain in more than one cancer type in the general adult cancer population. These show a wide range in reported prevalence by tumor site, but those cancers with more than 70% of patients with pain reported in more than one study are: • • • • Head and neck (mean 80%, range 67%–91%) Genitourinary (mean 77%, range 58%–90%) Esophagus (mean 74%, range 71%–77%) Prostate (mean 74%, range 56%–94%) One hundred percent of patients with advanced multiple myeloma (65) and with advanced sarcoma (64) were experiencing pain.
11. Ren K, Hylden JL, Williams GM, et al. The effects of a noncompetitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain 50:331–44, 1992. 12. Coderre TJ, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12:3665–70, 1992. 13. Mao J, Price DD, Hayes RL, et al. Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy.
9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. J. J. HIGGINSON Program: past, present, and future. J Pain Symptom Manage 12(2):65–72, 1996. World Health Organization (WHO). The World Health Report 1996, fighting disease, fostering development executive summary. Geneva: The World Health Organisation, 1996. Allende S, Carvell HC. Mexico: status of cancer pain and palliative care. J Pain Symptom Manage 12(2):121–3, 1996. Cherny NI. Israel: status of cancer pain and palliative care.